Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease

Xufeng Cena Research Center for Clinical Pharmacy & Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;b Department of Biochemistry & Molecular Medical Center, Zhejiang University School of Medicine, Hangzhou, China

Xiaoyan Xua Research Center for Clinical Pharmacy & Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;b Department of Biochemistry & Molecular Medical Center, Zhejiang University School of Medicine, Hangzhou, China

Hongguang Xiaa Research Center for Clinical Pharmacy & Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;b Department of Biochemistry & Molecular Medical Center, Zhejiang University School of Medicine, Hangzhou, China;c Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, ChinaCorrespondence[email protected]

Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date